FDA delivers less than half a loaf to INCY and LLY in approving Olumiant
Today the U.S. Food & Drug Administration did finally approve Baricitinib, now known as Olumiant, for the treatment of moderately-to-severely active rheumatoid arthritis. But the approval carries more restrictions than expected. The FDA approved only the 2...
It looks we might get a China trade deal before one on NAFTA
Today, House Speaker Paul Ryan announced a May 17 deadline for the Trump administration to submit a proposal NAFTA revision to Congress–if President Trump wants this Congress to vote on a revised agreement. The odds of an agreement emerging from current talks and moving on to Congress on that schedule are just about nil. At the same time news of significant horse trading is coming out of U.S.-China trade talks.
Closing my first two earnings surprise call options with gains of 49% and 70% in less than a month
With the Federal Reserve and Apple’s earnings behind us, this week the market has responded by strongly bidding up the prices of Nvidia and SolarEdge Technologies–and their options–strongly ahead of earnings announcements on May 9 and on May 10. I added call options on these stocks to my Volatility Portfolio on April 17 as the first move in my strategy for profiting from the 2018 earnings boom. My gains: 49% and 70%
So much for Argentina having turned the corner toward financial stability–selling ARGT and GGAL out of my Volatility Portfolio
It feels like panic rather than a plan. Because, I think, it is panic without a plan. The central bank of Argentina raised its benchmark interest rate another 3 percentage points today (that’s not 3 or 30 basis points but 300–a full 3 percentage points.) This comes after the central bank raised interest rates 3 percentage points last Friday. The benchmark rate now stands at 33.25%, the highest in the world
Positive catalysts are intact for Nektar Therapeutics
Shares of biotech rocket Nektar Therapeutics (NKTR) are down 23.25% since they traded at $106.91 on March 21, 2018. I can't find evidence that the positive catalysts that led me to recommend the stock for my Jubak Picks portfolio and the options for my Volatility...
Freeport McMoRan Copper & Gold delivers ugly earnings report–that’s good for my Put options (and I’m selling on the big jump)
Before the U.S. markets opened today Freeport McMoRan Copper & Gold (FCX) ) reported a big earnings miss. As of 2:30 p.m. New York time the shares were down 16.67%. That's good news for the May 18, 2018 Put options I added to my Volatility Portfolio on April 3,...
Trick or trend: 10-year Treasuries drop, yield climbs to February peak at 2.95%
The yield on the 10-year U.S. Treasury climbed to 2.95% today, up 4 basis points on the day. That equals the high yield for 2018 set back in February. The driver this time is an increase in commodity prices that has revived fears of inflation
Special premium report Part 1: My 2018 earnings boom profit strategy–and two picks
With the report of first quarter earnings season from Netflix (NFLX) on Monday, April 16, we’ve moved into the heart of earnings season. In most quarters traders began putting on plays for earnings announcements a few weeks before reporting starts. And they’ll keep making new bets over the next three weeks or so. In most quarters buying shares or options on companies about to report makes profitable sense. But this strategy is likely to be even more rewarding this year
Putting on the second half of my FCX options play–buying January 18 call options at $20 for the (eventual) recovery in copper prices as fear recedes
Whenever someone asks me "Do you like Stock XYZ? my first question in response is "Over what time period?" So for example, in the short run--say the next month or two--I don't much like shares of Amazon (AMZN) for the reasons that I laid out in my post on the stock...
Good news for Brazilian ETFs EWZ and EWZS: Central bank cuts interest rates again and signals that it’s not done either
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Jim’s Stock Alerts
Download Jim’s eBook for Free
